Abeona Therapeutics (ABEO) Current Leases (2019 - 2026)

Abeona Therapeutics' Current Leases history runs 8 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• In Q1 2026, Current Leases rose 107.5% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (up 107.5% YoY), while the FY2025 annual figure was $864000.0, up 4.98% from the prior year.
• Current Leases was $1.3 million for Q1 2026 at Abeona Therapeutics, up from $864000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.8 million in Q1 2022 to a low of $102000.0 in Q3 2025.
• Historically, Current Leases has averaged $1.3 million across 5 years, with a median of $1.3 million in 2026.
• The sharpest annual moves came in 2025 and 2026: Current Leases slumped 90.35% in 2025, then surged 107.5% in 2026.
• A 5-year view of Current Leases shows it stood at $1.8 million in 2022, then tumbled by 43.71% to $998000.0 in 2023, then decreased by 17.54% to $823000.0 in 2024, then grew by 4.98% to $864000.0 in 2025, then soared by 47.22% to $1.3 million in 2026.
• The last three Current Leases figures came in at $1.3 million (Q1 2026), $864000.0 (Q4 2025), and $102000.0 (Q3 2025), per Business Quant data.